COVID-19

News

Coronavirus won't be circulating in UK by August, says outgo...

Coronavirus won’t be circulating in the UK by August, according to the outgoing chief of the country’s vaccine rollout scheme, Dr Clive Dix.

News

Resourceful or risky-The UKs controversial COVID-19 vaccine strategy

UK 'planning to widen AstraZeneca COVID jab restrictions'

Reports are emerging that the UK may join other countries in imposing restrictions on the use of AstraZeneca's COVID-19 vaccine in younger people, after a fresh look at the risks and benefi

News

Nebuliser being filled. Copyright Vectura (002)

New UK biotech Inspira uncloaks with deal to develop inhaled...

UK biotech Inspira Pharmaceuticals has emerged from stealth mode with a deal with Vectura to develop an inhaled therapy for COVID-19 that could be ready for human testing within 12 months.&

News

Pfizer shares slump as support grows for COVID-19 vaccine pa...

Shares in COVID-19 vaccine manufacturers have taken a hit after the US signalled its support for waiving patents on them, a move aimed to boost global supplies of the life-saving shots.

Views & Analysis

Building a better future for people with rare diseases in all four UK nations

Creating a global life sciences superpower from the lessons ...

It’s time to take what the UK has learnt about the “Holy Trinity” of government, academia, and industry and apply it to creating a “life sciences superpower”, says health secretary Matt Han

News

Pfizer says COVID-19 jab could rake in $26bn this year

Pfizer expects revenues from its BioNTech-partnered COVID-19 vaccine to reach an eye-watering $26 billion this year, catapulting it to the top of the world's biggest-selling medicines.

Coronavirus won't be circulating in UK by August, says outgo...

UK 'planning to widen AstraZeneca COVID jab restrictions'

New UK biotech Inspira uncloaks with deal to develop inhaled...

Pfizer shares slump as support grows for COVID-19 vaccine pa...

Creating a global life sciences superpower from the lessons ...

Pfizer says COVID-19 jab could rake in $26bn this year

Otsuka grows in neuroplastogens with $1.225bn Transcend buy

Using AI-driven synthetic personas to take your insights fur...

COVID-19

Editor's Picks